Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.38 EUR | +1.81% | +6.12% | +6.96% |
26/04 | FAES FARMA : Q1 beat; full-year guidance re-affirmed | |
27/02 | FAES FARMA : Q4 profitability exceeded expectations |
Sales 2024 * | 476M 509M 42.48B | Sales 2025 * | 496M 531M 44.28B | Capitalization | 1.05B 1.12B 93.82B |
---|---|---|---|---|---|
Net income 2024 * | 89M 95.16M 7.94B | Net income 2025 * | 91M 97.3M 8.12B | EV / Sales 2024 * | 2.23 x |
Net Debt 2024 * | 9.8M 10.48M 874M | Net cash position 2025 * | 64.45M 68.91M 5.75B | EV / Sales 2025 * | 1.99 x |
P/E ratio 2024 * |
11.7
x | P/E ratio 2025 * |
11.4
x | Employees | 1,748 |
Yield 2024 * |
4.59% | Yield 2025 * |
4.66% | Free-Float | 91.13% |
1 day | +1.81% | ||
1 week | +6.12% | ||
Current month | +7.47% | ||
1 month | +6.79% | ||
3 months | +9.39% | ||
6 months | +16.75% | ||
Current year | +6.96% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Chief Executive Officer | - | - | |
Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | 19/18/19 | |
Chairman | - | 16/91/16 | |
Director/Board Member | - | 26/94/26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 773 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 3.38 | +1.81% | 352,943 |
25/24/25 | 3.32 | +1.37% | 297,907 |
24/24/24 | 3.275 | -0.30% | 316,838 |
23/24/23 | 3.285 | +3.30% | 435,056 |
22/24/22 | 3.18 | -0.16% | 197,605 |
Delayed Quote BME, April 26, 2024 at 09:05 pm IST
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+6.96% | 1.12B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- FAE Stock